Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Differential expression of CXCL9, CXCL10, and IFN-γ in vitiligo and alopecia areata patients.

Literature DB >> 27863059

Differential expression of CXCL9, CXCL10, and IFN-γ in vitiligo and alopecia areata patients.

Amal Maouia¹, Laura Sormani², Monia Youssef³, Ahmed N Helal¹, Asma Kassab⁴, Thierry Passeron^2,5.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2017 PMID： 27863059 DOI： 10.1111/pcmr.12559

Source DB: PubMed Journal: Pigment Cell Melanoma Res ISSN： 1755-1471 Impact factor: 4.693

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

1. Chemokines in Vitiligo Pathogenesis: CXCL10 and 12.

Authors: Khaled Gharib; Hend Gadallah; Ayman Elsayed
Journal: J Clin Aesthet Dermatol Date: 2021-09

2. RNAi-based modulation of IFN-γ signaling in skin.

Authors: Qi Tang; Jacquelyn Sousa; Dimas Echeverria; Xueli Fan; Ying-Chao Hsueh; Khashayar Afshari; Nicholas MeHugh; David A Cooper; Lorenc Vangjeli; Kathryn Monopoli; Ken Okamura; Annabelle Biscans; Adam Clauss; John E Harris; Anastasia Khvorova
Journal: Mol Ther Date: 2022-04-27 Impact factor: 12.910

3. Association of Clinical Markers With Disease Progression in Patients With Vitiligo From China.

Authors: Li Zhang; Shujun Chen; Yuli Kang; Xiuxiu Wang; Fang Yan; Min Jiang; Qianqian Wang; Ziqi Liu; Chengfeng Zhang; Leihong Xiang
Journal: JAMA Dermatol Date: 2020-03-01 Impact factor: 10.282

4. Increased Circulating CXCL10 in Non-Segmental Vitiligo Concomitant with Autoimmune Thyroid Disease and Alopecia Areata.

Authors: Li Zhang; Xinya Xu; Shujun Chen; Yuli Kang; Xiuxiu Wang; Chengfeng Zhang; Leihong Xiang
Journal: Ann Dermatol Date: 2019-07-01 Impact factor: 1.444

5. Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients.

Authors: Elisabetta Volpe; Cristina Maria Failla; Maria Luigia Carbone; Gabriele Madonna; Alessia Capone; Marianna Bove; Simona Mastroeni; Lauretta Levati; Mariaelena Capone; Paolo Antonio Ascierto; Federica De Galitiis; Stefania D'Atri; Cristina Fortes
Journal: Sci Rep Date: 2022-03-31 Impact factor: 4.996

Differential expression of CXCL9, CXCL10, and IFN-γ in vitiligo and alopecia areata patients.

1. Chemokines in Vitiligo Pathogenesis: CXCL10 and 12.

2. RNAi-based modulation of IFN-γ signaling in skin.

3. Association of Clinical Markers With Disease Progression in Patients With Vitiligo From China.

4. Increased Circulating CXCL10 in Non-Segmental Vitiligo Concomitant with Autoimmune Thyroid Disease and Alopecia Areata.

5. Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients.

Review 6. Advances in vitiligo: Update on therapeutic targets.

7. Urinary metabolomic investigations in vitiligo patients.

8. CXCL9 as a key biomarker of vitiligo activity and prediction of the success of cultured melanocyte transplantation.